Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 1311 — Requirements for Electronic Orders and Prescriptions · § 1311.116

§ 1311.116. Additional requirements for biometrics.

429 words·~2 min read·/us/cfr/t21/s§ 1311.116·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)If one of the factors used to authenticate to the electronic prescription application is a biometric as described in § 1311.115, it must comply with the following requirements.
(b)The biometric subsystem must operate at a false match rate of 0.001 or lower.
(c)The biometric subsystem must use matching software that has demonstrated performance at the operating point corresponding with the false match rate described in paragraph
(b)of this section, or a lower false match rate. Testing to demonstrate performance must be conducted by the National Institute of Standards and Technology or another DEA-approved government or nongovernment laboratory. Such testing must comply with the requirements of paragraph
(h)of this section.
(d)The biometric subsystem must conform to Personal Identity Verification authentication biometric acquisition specifications, pursuant to NIST SP 800-76-1 as incorporated by reference in § 1311.08, if they exist for the biometric modality of choice.
(e)The biometric subsystem must either be co-located with a computer or PDA that the practitioner uses to issue electronic prescriptions for controlled substances, where the computer or PDA is located in a known, controlled location, or be built directly into the practitioner's computer or PDA that he uses to issue electronic prescriptions for controlled substances.
(f)The biometric subsystem must store device ID data at enrollment (i.e., biometric registration) with the biometric data and verify the device ID at the time of authentication to the electronic prescription application.
(g)The biometric subsystem must protect the biometric data (raw data or templates), match results, and/or non-match results when authentication is not local. If sent over an open network, biometric data (raw data or templates), match results, and/or non-match results must be:
(1)Cryptographically source authenticated;
(2)Combined with a random challenge, a nonce, or a time stamp to prevent replay;
(3)Cryptographically protected for integrity and confidentiality; and
(4)Sent only to authorized systems.
(h)Testing of the biometric subsystem must have the following characteristics:
(1)The test is conducted by a laboratory that does not have an interest in the outcome (positive or negative) of performance of a submission or biometric.
(2)Test data are sequestered.
(3)Algorithms are provided to the testing laboratory (as opposed to scores or other information).
(4)The operating point(s) corresponding with the false match rate described in paragraph
(b)of this section, or a lower false match rate, is tested so that there is at least 95% confidence that the false match and non-match rates are equal to or less than the observed value.
(5)Results of the testing are made publicly available.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.